Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

• Status: Completed
• Trial end date: 2004-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UCB Pharma
• Treatments: Cetirizine; Levocetirizine; Loratadine

Criteria

Inclusion Criteria:

• Male ore female, 16 to 60 years old (inclusive)

• two-year history of allergic rhinitis due to house dust mite

Exclusion Criteria:

• An ear, nose or throat (ENT) infection

• asthma requiring daily drug therapy other than ß2 inhaled agonists taken prn

• atopic dermatitis or urticaria requiring an antihistamine or corticosteroid treatment

• an associated ENT disease

• use of decongestants

• nasal or ocular topical treatment

• desensitivation